Catalyst Pharmaceuticals (CPRX) Goodwill & Intangibles (2022 - 2026)

Catalyst Pharmaceuticals (CPRX) has 5 years of Goodwill & Intangibles data on file, last reported at $122.0 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 46.44% year-over-year to $122.0 million; the trailing twelve-month figure through Mar 2026 stood at $122.0 million (down 46.44% YoY), and the FY2025 full-year result was $131.7 million, down 42.18% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $122.0 million, down from $131.7 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $227.7 million in Q2 2024 and bottomed at $32.5 million in Q4 2022.
• The 5-year median for Goodwill & Intangibles is $184.1 million (2023), against an average of $166.1 million.
• The widest annual swing landed in 2023, when Goodwill & Intangibles jumped 497.61%; it then tumbled 46.44% in 2026.
• A 5-year view of Goodwill & Intangibles shows it stood at $32.5 million in 2022, then surged by 497.61% to $194.0 million in 2023, then grew by 17.35% to $227.7 million in 2024, then plunged by 42.18% to $131.7 million in 2025, then retreated by 7.37% to $122.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $122.0 million (Q1 2026), $131.7 million (Q4 2025), and $128.6 million (Q3 2025), per Business Quant data.

Peer Comparison